tradmap

PGNY Progyny, Inc.

$29.43 +0.72%

Data as of close

Healthcare · Services-Misc Health & Allied Services, Nec

Progyny, Inc. (PGNY) is a healthcare company in the Services-Misc Health & Allied Services, Nec industry, with a market capitalization of $2.3 billion. Shares last traded at $29.43, 11.0% below their 52-week high. Over the past year the stock is up 57.9%. PGNY trades at a price-to-earnings ratio of 28.71, above the Services-Misc Health & Allied Services, Nec median of 26.76. Net profit margin is 6.0%, above the peer median of 5.4%. Revenue grew 10.4% year over year.

Market Cap
$2.3B
Shares Out
76.7M
EPS (TTM)
$0.92
P/E (TTM)*
28.71
P/S Ratio
1.72
P/B Ratio
4.98
Dividend / Share
—
Dividend Yield
—
52-Week High
$33.05
52-Week Low
$16.09
Volume (venue)
69,121
Avg Vol (3m, venue)
62,140.19

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
+4.57%
1M
+16.58%
3M
-6.56%
6M
+55.56%
YTD
+14.54%
1Y
+57.86%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
63.32
SMA (50)
$26.96
SMA (200)
$24.40
Price vs SMA50
+9.15%
Price vs SMA200
+20.58%
ATR (14)
$0.97

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$1.3B
Net Income
$79M
Gross Margin
24.6%
Operating Margin
8.6%
Net Margin
6.0%
Return on Equity
17.3%
Return on Assets
11.0%
Current Ratio
2.14
Debt / Equity
0.58
Revenue Growth (YoY)
+10.4%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-06-30. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 $0.34 2026-08-07
Q1 2026 $0.29 2026-05-08
Q4 2025 $0.14 2026-02-27
FY 2025 $0.65 2026-02-27
Q3 2025 $0.15 2025-11-07
Q2 2025 $0.19 2025-08-08

Full earnings history →

Services-Misc Health & Allied Services, Nec peers

PGNY vs 11 industry peers (Services-Misc Health & Allied Services, Nec), by market cap. Data as of close

P/E vs peers
28.71 / 26.76 med
+7% premium
P/S vs peers
1.72 / 1.55 med
+11% premium
Net margin vs peers
6.0% / 5.4% med
above median
1–11 of 11
DVADaVita$11.7B12.700.826.5%-1.02%
SHCSotera Health Co$5.1B30.934.1613.4%-2.26%
PGNYProgyny, Inc.$2.3B28.711.726.0%+0.72%
AGLAgilon Health, Inc.$1.5B—0.25-3.9%+2.46%
VMDVIEMED HEALTHCARE, INC.$360M24.801.194.8%-2.48%
PARKPark Dental Partners, Inc.$100M———-0.54%
CCELCRYO CELL INTERNATIONAL INC$43M—1.39-6.2%+3.38%
MGRXMANGOCEUTICALS, INC.$5M—15.66—-2.51%
BRTXBioRestorative Therapies, Inc.$2M—5.34—+6.38%
NIVFNewGenIvf Group Ltd————-7.75%
FMSFresenius Medical Care Ag————+0.67%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.